Free Account Opening + AMC Free Demat
Loading...

Parabolic Drugs IPO vs Technofab IPO

Comparision between Parabolic Drugs IPO and Technofab IPO.

IPO Details

Parabolic Drugs IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Technofab IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Parabolic Drugs IPO Technofab IPO
Logo Parabolic Drugs IPO Logo Technofab IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers ICICI Securities Limited

Spa Capital Advisors Ltd
Collins Stewart Inga Private Limited
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the Technofab IPO is up to ₹71.66 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of Technofab IPO is ₹240.00 per share.

  Parabolic Drugs IPO Technofab IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹75.00 per share ₹230.00 per share
Issue Price (Upper) ₹85.00 per share ₹240.00 per share
Issue Price (Final) ₹75.00 per share ₹240.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 80 shares 25 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 2,66,66,667 shares 29,90,000 shares
Issue Size Total (Amount) up to ₹200.00 Cr up to ₹71.66 Cr

IPO Timetable

Parabolic Drugs IPO opens on Jun 14, 2010, while Technofab IPO opens on Jun 29, 2010. The closing date of Parabolic Drugs IPO and Technofab IPO is Jun 17, 2010, and Jul 02, 2010, respectively.

  Parabolic Drugs IPO Technofab IPO
Anchor Bid Date
Issue Open Jun 14, 2010 Jun 29, 2010
Issue Close Jun 17, 2010 Jul 02, 2010
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Parabolic Drugs IPO P/E ratio is , as compared to Technofab IPO P/E ratio of .

  Parabolic Drugs IPO Technofab IPO
Financial
ParticularsFor the year/period ended (Rs. in Crore)
30-Sept-0931-Mar-0931-Mar-0831-Mar-0731-Mar-0631-Mar-05
Total Income233.43396.94273.94150.5690.1250.90
Profit After Tax (PAT)12.4121.0929.6713.588.223.27
Promoter Shareholding (Pre-Issue) 63.2% 51%
Promoter Shareholding (Post-Issue) 46.5%
P/E Ratio
Market Cap
ROE
ROCE 6.21%%
Debt/Equity
EPS
RoNW 19.96%% 38.2%%

Shares Offered

In the Parabolic Drugs IPO retail investors (RII) are offered 91,58,334 shares while in Technofab IPO retail investors are offered 91,58,334 shares. Qualified institutional buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 14,70,000 shares in Technofab IPO.

  Parabolic Drugs IPO Technofab IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 1,30,83,333 shares 14,70,000 shares
NII 39,25,000 shares 4,41,000 shares
RII 91,58,334 shares 10,29,000 shares
Employee 5,00,000 shares 50,000 shares
Others
Total 2,66,66,667 shares 29,90,000 shares

Bids Received (Subscription)

Parabolic Drugs IPO subscribed 1.04x in total, whereas Technofab IPO subscribed 12.78x.

  Parabolic Drugs IPO Technofab IPO
QIB (times) 1.48x 4.28x
NII (times) 1.20x 48.85x
Big NII (times)
Small NII (times)
RII (times) 0.40x 10.03x
Employee (times) 0.11x 1.10x
Other (times)
Total (times) 1.04x 12.78x

Comments

Add a public comment...